Dublin, Jan. 19, 2017 -- Research and Markets has announced the addition of the "Global Drug Delivery Technologies Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
Latest Market Trends
- Growing demand for Drug Delivery Devices in Emerging Markets
- Advancing delivery of biopharmaceuticals
- New biomaterials for medical devices
- Growth Opportunities/Investment Opportunities
The Global Drug Delivery Technologies Market is poised to grow at a CAGR of around 7.9% over the next decade to reach approximately $2,222 billion by 2025.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
This industry report analyzes the global markets for Drug Delivery Technologies across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Key Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Growing demand for Drug Delivery Devices in Emerging Markets
3.1.2 Advancing delivery of biopharmaceuticals
3.1.3 New biomaterials for medical devices
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
4 Drug Delivery Technologies Market, By Route of Administration
4.1 Injectable Drug Delivery
4.2 Implantable Drug Delivery
4.3 Oral Drug Delivery
4.4 Ocular Drug Delivery
4.5 Pulmonary Drug Delivery
4.6 Transmucosal Drug Delivery
4.7 Nasal Drug Delivery
4.8 Topical Drug Delivery
5 Drug Delivery Technologies Market, By End User
5.1 Hospitals
5.2 Home care settings
5.3 Clinics
5.4 Diagnostic Centres
5.5 Other End Users
6 Drug Delivery Technologies Market, By Geography
7 Leading Companies
7.1 3M Company
7.2 Merck & Co., Inc.
7.3 Pfizer Inc
7.4 Johnson & Johnson
7.5 Nektar Therapeutics Ltd.
7.6 Bayer AG
7.7 pSivida Corp
7.8 Sanofi
7.9 Generex Biotechnology
7.10 Abbott Medical Optics
7.11 Novartis AG
7.12 Flamel Technologies Inc.
7.13 Vectura Group Plc.
7.14 Antares Pharma
7.15 Skye Pharma Plc.
For more information about this report visit http://www.researchandmarkets.com/research/rtb78p/global_drug
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery


U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 



